5111- Immunization Quiz (table)
Measles, Mumps, Rubella (Live) MMR: M-M-R II MMRV (MMR + Varicella): ProQuad ADR
- ADR: injection site reactions, arthralgia, myalgia, Rash
Zoster Virus Vaccines (for herpes zoster/shingles): Shingrix, Zostavax ADR
- ADR: injection site reactions, headache, flu-like symptoms, fever
Measles, Mumps, Rubella (Live) MMR: M-M-R II MMRV (MMR + Varicella): ProQuad Patient info
- Adults born before 1957 are generally considered immune to measles and mumps
Diphtheria Toxoid, Tetanus Toxoid, acellular Pertussis
- DTaP has 3-5 times as much of the diphtheria component than Tdap or Td - Tdap has lower diphtheria and acellular pertussis dose to avoid local reactions in adults - Tdap can be administered regardless of the interval since the last tetanus and diphtheria toxoid-containing vaccine ADR: Injection site reactions, arthus reactions, swelling, fever
Influenza vaccines patient education
- Preferable to administer before October (might take 2 weeks to work) - Trivalent protect against 3 viruses: two influenza A's and one influenza B - Quadrivalent protect against two influenza A's and two influenza B's - Inactivated are produced using eggs - ADR: fever, malaise, myalgia, injection site reactions
Zoster Virus Vaccines (for herpes zoster/shingles): Shingrix, Zostavax patient education
- Zostavax: live attenuated, higher strength than varicella vaccine - Shingrix: recombinant, adjuvanted zoster
Pneumococcal: 23-valent polysaccharide vaccine (PPSV23) Pneumovax is good for...
-19-64 that have asthma -19-64 who are smokers -2-64 who have chronic illness
What are the populations and schedules for meningococcal vaccines: -MenB (covers serogroup B) -Bexsero: for age 10-25 yrs -Trumenba: for age 10-25 yrs
-2 doses (given 1 mo apart) -2 doses given 6 mo. apart. If high risk of meningococcal disease or during an outbreak: give 3 doses at months 0, 1-2, and 6 -patients age >/= 10 yrs with high risk: asplenia/sickle cell disease, complement component deficiencies or eculzumab use -lab workers with N. meningitidis -during an outbreak -optional for patients age 16-23 yrs. who are not at high risk but want the vaccine (if given the preferred age is 16-19 yrs)
Pneumococcal: 23-valent polysaccharide vaccine (PPSV23) Pneumovax- IM or SC
-2 doses for adults 19-64 yrs with immunocompromising conditions and asplenia -all adults >/=65 yrs: 1 dose
HPV vaccine patient information
-ACIP recommends routine vaccination at age 11 to 12 years (can start at 9 yo.) for patients with any history of sexual abuse or assault, vaccination should be started at 9 yrs. Catch-up vaccination is recommended for all persons through age 26 years - Individuals 27-45 years who are not adequately vaccinated may be vaccinated with shared clinical decision making - Consider recommending to adults >27yo who are more at risk for contracting HPV: new sex partner or multiple partners - Caution for fainting, administer to seated patient and monitor after vaccination - ADR: injection site reactions, headache, fever, fatigue, myalgia - Vaccine is more effective if given before sexual activity begins
Live- Varicella Virus Vaccine (for chickenpox): Varivax ADR
-Injection site reactions -rash -fever -Malaise -Arthralgia
what are the vaccines for live Rotavirus (2)
-RotaTeq (RVS) -Rotarix (RV1)
Influenza vaccines -all IM except for fluzone intradermal and quadrivalent Trivalent Inactivated - Fluvirin: > 4 yrs Quadrivalent Inactivated - Afluria: > 5 yrs - FluLaval: > 6 mos - Fluarix: > 3 yrs - Flucelvax Quadrivalent: ≥ 4 yrs - Flubok Quadrivalent: ≥ 18 yrs - Fluzone Intradermal - Fluzone High Dose: ≥ 65 yrs - Fluad (adjuvanted): ≥ 65 yrs - Quadrivalent: 18-64 yrs Quadrivalent Live Attenuated: - FluMist: Healthy people 2-49 years -intranasal
-Routine annual vaccination recommended for all persons ≥ 6 mo or older -Children 6 mo - 8 yrs receiving influenza vaccination for the first time need 2 doses, administered at least 4 weeks apart
Diphtheria Toxoid, Tetanus Toxoid, acellular Pertussis (dosage and population) DTaP: Dapacel, Infanrix DTaP-IPV: Kinrix, Quadracel DTaP-HepB-IPV: Pediarix DTaP-IPV/Hib: Pentacel DTaP-IPV/Hib/HepB: Vaxelis
-Routine childhood vaccine series: 5 doses given at ages 2,4,6, 15-18 mos and 4-6 yrs -For children younger than 7 years of age
Poliovirus (IPV)
-a routine childhood vaccine series given between the ages 2 months to 6 years -series of 4 vaccines given at 2 months, 4 months, 6-18 months, and 4-6 years -first dose can be given as early as 6 weeks
Rotavirus (live) vaccine populations and schedules
-a routine childhood vaccine series given btw ages 6 weeks-8 months -the first dose must be administered before 15 weeks of age and can be given as early as 6 weeks -the last dose must be administered by 8 months of age
Pneumococcal: 13-valent conjugate vaccine (PCV13) Prevnar 13 population -IM
-all children age 6 wks to 5 years: 4-dose series given at age 2, 4, 6, and 12 to 15 months -adults >/=65 yo with immunocompromising conditions and asplenia: 1 dose
For which adults is Hepatitis B: Engerix-B, Heplisav-B, Recombivax vaccines good for ?
-healthcare workers -patients with ESRD (on dialysis) -chronic liver disease (including HCV) -HIV -diabetes (age 19-59 yrs, or >/=60 yrs at health care provider discretion) -IV drug abusers -men who have sex with men -anyone with multiple sex partners -incarcerated people -some travelers
ADR of Hepatitis A: Havrix, VAQTA
-injection site reactions -fever
HepB vaccines side effects
-injection site reactions -headache -fatigue -fever
Pneumococcal: 13-valent conjugate vaccine (PCV13) Prevnar 13 population ADR
-injection site reactions -headache -fever -fatigue -myagia
What are ADR's of meningococcal vaccines
-injection site reactions -headache -fever -malaise
What is the ADRs of rotavirus (live) vaccine
-irritability or mild, temporary diarrhea or vomiting -risk of intussusception (a type of bowel blockage) usually a week after the 1st or 2nd dose
contraindications for Rotavirus (live)
-severe (life-threatening) allergic reaction to a previous dose of rotavirus vaccine -severe (life-threatening) allergy to any component of rotavirus vaccine -severe combined immunodeficiency (SCID) -previous episode of intussusception
Contraindications for IPV
-severe (life-threatening) allergic reaction to an IPV vaccine -severe (life-threatening) allergy to any component of IPV vaccine
What are the live vaccines?
-zoster (zostavax) -LAIV (FluMist Quadrivalent) -MMR -Rotarix, RotaTeq -Varicella (varivax)
Males are selected to get Human Papillomavirus Vaccines (HPV9: 9-Valent: Gardasil) for:
1) Anal cancer caused by HPV types 2) Genital warts (condyloma acuminata) caused by HPV 3) Precancerous or dysplastic lesions caused by HPV A) Anal intraepithelial neoplasia (AIN) grades 1, 2, and 3 -If started before age 15 or older (15-26yrs), or if immunocompromised (regardless of age)-3 dose (at months 0, 1-2, and 6 -FDA-approved up to age 45, ACIP recommendations have not changed
females are selected to get Human Papillomavirus Vaccines (HPV9: 9-Valent: Gardasil) for
1) cervical, vulvar, vaginal, and anal cancer caused by Human Papillomavirus (HPV) types ... 2) genital warts (condyloma acuminata) caused by HPV types 6 & 11 3) and the following precancerous or dysplastic lesions caused by HPV types... A) cervical intraepithelial neoplasia (CIN) grade 2/3 and cervical adenocarcinoma in situ (AIS) B) cervical intraepithelial neoplasia (CIN) grade 1 C) Vulvar intraepithelial neoplasia (VIN) grade 2 and grade3 D) Vaginal intraepithelial neoplasia (VAIN) grade 2 and grade 3 E) Anal intraepithelial neoplasia (AIN) grades 1, 2, and 3
Anyone without evidence of immunity to varicella should receive -- doses of ----
2 doses of varivax
Quadrivalent meningococcal conjugate vaccines (MCV4) include ...
A, C, W, Y
---vaccine is required by Saudi Arabia for travel to the Hajj and Umrah pilgrimages; proof of vaccination is required
ACWY vaccine (meningococcal)
influenza vaccines CI
Allergy to previous influenza vaccination allergy to eggs (except for Flucelvax) Live, attenuated vaccine CI: severe egg allergy, use of aspirin-containing products, use of influenza antiviral medications in the past 48 hrs, children age 2-4 yrs with asthma or a wheezing episode in the last 12 mos, close contact with an immunosuppressed person
Measles, Mumps, Rubella (Live) MMR: M-M-R II MMRV (MMR + Varicella): ProQuad CI
CI: -Pregnancy or if immunocompromised -Febrile illness
Diphtheria Toxoid, Tetanus Toxoid, acellular Pertussis
CI: For pertussis-containing vaccines: encephalopathy (e.g. coma, decreased level of consciousness, prolonged seizures) that is not attributable to another cause within 7 days of receiving the vaccine
Zoster Virus Vaccines (for herpes zoster/shingles): Shingrix, Zostavax contraindications
CI: Recombinant Zoster Vaccine (Shingrix): lactation Zoster Vaccine Live (Zostavax) hypersensitivity to gelatin or neomycin. Immunosuppression or immunodeficiency Both: pregnancy
Used for routine vaccine series in infants and children < 7yo who have a contraindication to the acellular pertussis antigen in DTaP: 3 doses, 0,1,6-12 M
DT
which HEPB vaccines are a 3 dose series given at month 0, 1, and 6 (can be completed in 4 months if necessary, but requires a booster at 1 year if the series is accelerated
Energix-X and Recombivax HB
-a routine childhood vaccine series given btw 2-15 months -ActHIB and Hiberix: 3-dose primary series (2, 4, & 6 months) followed by booster (15-16 months) what is this vaccine
Haemophilus influenzae type b (Hib) specific vaccines: Hib: ActHIB, Hiberix, PedvaxHIB
which vaccine is given to these specific adults: -men who have sex with men -illicit drug users -chronic liver disease -homeless individuals -clotting factor disorders -travelers to countries with high Hepatitis A incidence or anyone else who wants it
Hepatitis A: Havrix, VAQTA for adults -2 doses at least 6 months apart
which vaccine is a 2-dose series given at month 0 and 1 and should not be used in pregnant women
Hepisav-B (age >/= 18 yrs)
Live- Varicella Virus Vaccine (for chickenpox): Varivax contraindications
Hypersensitivity to gelatin or neomycin immunodeficiency or immunosuppression -active, untreated TB -pregnancy
Diphtheria Toxoid, Tetanus Toxoid, acellular Pertussis administration
IM
Haemophilus influenzae type b (Hib) route of administration
IM
Hepatitis A: Havrix, VAQTA and Hepatitis B: Engerix-B, Heplisav-B, Recombivax HB route of administration
IM
How are meningococcal vaccines administered
IM
administration of IPV (Polio)
IM
Varicella (live) Zoster Virus Vaccines (for herpes zoster/shingles): Shingrix, Zostavax
IM (Shingrix), SC (Zostavax)
most adults do not need this vaccine because they were already vaccinated against the disease as children. some adults are at higher risk and should consider it if traveling to certain parts of the world, laboratory workers who might handle this virus, and health care workers treating these patients
IPV (poliovirus)
contraindication for Hepatitis A: Havrix, VAQTA
Immediately and/or severe allergic or hypersensitivity reaction to hepatitis A containing vaccines or any component of the formulation, including neomycin
Children: routine vaccination series; 2 doses given at age 12-15 mo and 4-6 years ProQuad: Patients age 12 mo - 12 yrs Adults: 1-2 doses if no evidence of immunity 2 doses (4 wks apart): healthcare workers, HIV patients with CD4 count ≥ 200 cells/mm3 for at least 6 mos, nonpregnant women of childbearing age (with no evidence of immunity to rubella), international travels, household contacts of immunocompromised people and students in postsecondary educational institutions.
Measles, Mumps, Rubella (Live) MMR: M-M-R II MMRV (MMR + Varicella): ProQuad
Route of administration for Rotavirus (live)
Oral drops
If vaccinated because of a chronic illness before the age of 65, patients must have 5 years in between ---- doses
Pneumovax23
Diphtheria Toxoid, Tetanus Toxoid, acellular Pertussis
Precaution: Guillain-Barre syndrome within 6 weeks of a previous diphtheria, tetanus and/or pertussis vaccine
Influenza vaccines precautions
Precaution: Guillain-Barre syndrome within 6 wks of a previous influenza vaccination Live, attenuated vaccine: asthma in pts ≥5 yrs, underlying conditions that predispose to influenza complications (e.g. chronic lung, heart, renal, hepatic neurologic, hematologic and metabolic disorders, including diabetes)
Zoster Virus Vaccines (for herpes zoster/shingles): Shingrix, Zostavax precautions
Precaution: Some antivirals (e.g. acyclovir, valacyclovir, etc) can interfere with the live vaccines (varivax and Zostavax). Stop 24 hours before vaccine administration and do not take for 14 days
Quadrivalent Live Attenuated: FluMist: Healthy people 2-49 years
Pregnancy or immunocompromised Hypersensitivity to egg protein
which vaccine gives 3 doses at ages 2, 4, & 6 months
RotaTeq
which vaccine gives 2 doses at ages 2 and 4 months
Rotarix
Live- Varicella Virus Vaccine (for chickenpox): Varivax dosage
Routine childhood vaccine series: 2 doses given at age 12-15 mos and 4-6 yrs
What are the populations and schedules for Meningococcal vaccines: -MenACWY: covers serogroups A, C, W, Y -MCV4 (conjugate vaccines) -Menactra: for age 9 months-55 years -can be used in adults >/=56 yrs if needed
Routine vaccination: -Adolescents: 2 dose series given at 11-12 yrs and at 16 yrs (booster dose) -special populations at high risk: travelers to certain countries such as the meningitis belt in Sun-Saharan Africa -Age >/=2 months with: HIV, asplenia/sickle cell disease, complement component deficiencies or eculizumab use: 2 doses at least 8 wks apart. 1 dose every 5 yrs after completing the 2-dose primary series -lab workers with N. meningitidis exposure -1st year college students (age </=21 yrs) living in resident housing, if not up-to-date -military recruits -the number of doses and timing (intervals) will depend on age and specific risk. People with ongoing risk of meningococcal disease should be revaccinated every 5 yrs.
Live- Varicella Virus Vaccine (for chickenpox): Varivax ROA
SC
Measles, Mumps, Rubella (Live) MMR: M-M-R II MMRV (MMR + Varicella): ProQuad
SC
--- is available in a separate vaccine. Use in addition to the quadrivalent meningococcal conjugate vaccines
Serogroup B (MenB)
Varicella (live) Zoster Virus Vaccines (for herpes zoster/shingles): Shingrix, Zostavax
Shingrix is preferred. ACIP recommends routine vaccination (2 doses given at month 0 and month 2-6) in patients age ≥ 50 years, including those who previously received varicella virus vaccine or Zostavax (wait at least 8 weeks after Zostavax before starting the 2-dose series of Shingrix) If second dose if given less than 4 weeks after the first then it must be repeated If patient is late on receiving the second dose do not restart the series or use Zostavax in its place Second dose can be given late if Shingrix is in short supply without having to repeat the series Vaccinate even if the pt has a history of zoster infection, since recurrence is possible Zostavax (if used) is recommended in patients ≥ 60 yrs (1 dose) In general, it's okay to give these vaccines to patients with low-level immunosuppression, which includes: prednisone less than 20 mg equivalent/day for two weeks or longer methotrexate less than 0.4 mg/kg/week azathioprine less than 3 mg/kg/day 6-mercaptopurine less than 1.5 mg/kg/day
Routine booster given every 10 years in patients ≥7 yrs Wound prophylaxis: for deep or dirty wounds, revaccinate with Td if it has been more than 5 years since the last dose. Tetanus immunoglobulin (TIG) may be required if no previous tetanus vaccines have been given. Can use Tdap x1 if never received
Td: Tenivac
1x booster at age ≥ 11 years (with no previous record of Tdap) Recommended in: 1) Pregnant or postpartum women, with each pregnancy after 20 wks of gestation (27-36 weeks optimal) 2) Close contacts of infants younger than age 12 mo, if not up-to-date 3) Healthcare personnel with direct patient contact, if not up-to-date 4) Children age 7-10 years who did not get fully vaccinated with the DTaP series, give a single dose of Tdap instead of DTap
Tdap: Adacel, Boostrix
Can be used in place of Td for 10yr booster vaccine, tetanus prophylaxis for wounds, or in a Catch-up schedule
Tdap: Adacel, Boostrix
Hepatitis A: Havrix, VAQTA dosing for children
a routine childhood vaccine series: 2 doses given at age 12 mo then 6-18 mos later
ADR of IPV
a sore spot with redness, swelling, or pain where the shot is given can happen after polio vaccine
at what ages can people get Human Papillomavirus Vaccines (HPV9: 9-Valent: Gardasil)
age 9-45 yrs in both genders (for selected patients) -preferred age is 11-12 yrs
Fluzone Quadrivalent 0.5 mL single-dose prefilled syringes are indicated for use in
ages 3 years and older
Fluzone Quadrivalent 0.25 ml single-dose prefilled syringes are indicated for use in
ages 6 months to 35 months
Haemophilus influenzae type b (Hib) contraindications
hypersensitivity to Haemophilus b polysaccharide, tetanus toxoid-containing vaccine (Hiberix and ActHIB only), or any component of the formulation
HepB vaccines contraindications
hypersensitivity to yeast
Haemophilus influenzae type b (Hib) ADR
injection site reactions
Pneumococcal: 23-valent polysaccharide vaccine (PPSV23) Pneumovax shared clinical decision
making with healthy patients age 65 and older when considering PCV13
HBIG vaccine is given at the same time as the first dose---
needs to be in a different limb for best efficacy
Hepatitis B: Engerix-B, Heplisav-B, Recombivax children dosing
routine childhood vaccine series started within 24 hours after birth; 3 doses given at age 0, 1-2 and. 6-18 months
Pneumococcal: 23-valent polysaccharide vaccine (PPSV23) Pneumovax contraindications
severe allergic reaction (e.g. anaphylactic/ anaphylactoid reaction) to pneumococcal vaccine or any component of the formulation
Pneumococcal: 13-valent conjugate vaccine (PCV13) Prevnar 13 population contraindications
severe allergic reaction (e.g. anaphylaxis) to pneumococcal vaccine, any component of the formulation, or any diphtheria toxoid-containing vaccine
Contraindication for meningococcal vaccines: -MenACWY: covers serogroups A, C, W, Y -MCV4 (conjugate vaccines) -Menactra: for age 9 months-55 years -can be used in adults >/=56 yrs if needed
severe hypersensitivity to other meningococcal-containing vaccines or any component of the formulation including diphtheria toxoid or CRM197 (a diphtheria toxin carrier protein)
Contraindications for MenB: Covers serogroup B Bexsero: for age 10-25 yrs Trumenba: for age 10-25 yrs
severe hypersensitivity to the meningococcal group B vaccine or any comment of the formulation
Live- Varicella Virus Vaccine (for chickenpox): Varivax precaution
some antivirals (e.g. acyclovir, valacyclovir, etc) can interfere with the live vaccines (varivax and zostavax). Stop 24 hours before vaccine administration and do not take for 14 days